Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

AAM. 2014; 3(1-2): 20-28


A Preliminary Pharmacognostical and Pharmaceutical Evaluation of Bala Chaturbhadra Avaleha

Abhishek J Joshi, Aparna K, Rajagopala S, Kalpana S Patel, Harisha C R, Vinay J Shukla.

Abstract
Aims: Balachaturbhadra Avaleha has been prepared and studied for its pharmacognosy and pharmaceutical parameters.
The adopted formulation is based on Balachaturbhadra Churna of Chakradatta. Though Balachaturbhadra Churna has
significant efficacy in pediatric disorders it has a few difficulties as a medicament like non acceptability by children,
lower shelf life, bitter taste etc. Considering these inconveniences the composition has been converted to Balachaturbhadra
Avaleha.Methods and Material: The present study provides details of preparation of Balachaturbhadra Avaleha and
methods employed in pharmacognosy and pharmaceutical parameters. Results: Pharmacognostical and phytochemistry
observations revealed the specific characters of all active constituents used in the preparation which indicated authenticity
of raw drugs. Starch grain cells, calcium oxalate, tannin and fibres were the characteristic features observed in microscopic
study of the formulation. The phyto-chemical evaluation of Balachaturbhadra Avaleha shows that the presence of
carbohydrates, steroids, cardiac glycosides and flavanoids. The preliminary HPTLC study of the compound reveals the
components are more sensitive to short UV 254nm having 15 spots compared to long UV 366nm with 09 spots. Conclusions:
Evaluation of Balachaturbhadra Avaleha can be used as a reference standard for further quality control researches for
manufacturing and processing of Balachaturbhadra Avaleha.

Key words: Balachaturbhadra Churna, Balachaturbhadra Avaleha, pharmacognosy, pharmaceutical parameter , HPTLC



Similar Articles

Capillary Electrophoretic Analysis of Isolated Sulfated Polysaccharides to Characterize Pharmaceutical Products.
Shriver Z, Sasisekharan R
Methods in molecular biology (Clifton, N.J.). 2022; 2303(): 329-339

Extremely Low Vapor-Pressure Data as Access to PC-SAFT Parameter Estimation for Ionic Liquids and Modeling of Precursor Solubility in Ionic Liquids.
Bülow M, Greive M, Zaitsau DH, Verevkin SP, Held C
ChemistryOpen. 2021; 10(2): 216-226

Focusing on functional knee parameter determination to develop a better clinical gait analysis protocol.
Leboucher J, Salami F, Öztürk O, Heitzmann DWW, Götze M, Dreher T, Wolf SI
Gait & posture. 2021; 84(): 127-136

Preferences of patients regarding community pharmacy services: A discrete choice experiment.
van de Pol JM, Heringa M, Koster ES, Bouvy ML
Health policy (Amsterdam, Netherlands). 2021; ():

Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.
Brautigan DL, Farrington C, Narla G
Clinical science (London, England : 1979). 2021; 135(13): 1545-1556


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites